Cycloastragenol ameliorates experimental heart damage in rats by promoting myocardial autophagy via inhibition of AKT1-RPS6KB1 signaling
Authors:
- 1 November 2018
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 107, 1074-1081
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation Project (81273716)
- Nanjing Science and Technology Project (201201067)
- Jiangsu Province "Six Talents Peak" Funding Project (2015-WSN-067)
This publication has 29 references indexed in Scilit:
- Histone Deacetylase Inhibition Blunts Ischemia/Reperfusion Injury by Inducing Cardiomyocyte AutophagyCirculation, 2014
- Dietary safety of cycloastragenol from Astragalus spp.: Subchronic toxicity and genotoxicity studiesFood and Chemical Toxicology, 2014
- Enhanced autophagy ameliorates cardiac proteinopathyJournal of Clinical Investigation, 2013
- Novel monofunctional platinum (II) complex Mono-Pt induces apoptosis-independent autophagic cell death in human ovarian carcinoma cells, distinct from cisplatinAutophagy, 2013
- A Novel Telomerase Activator Suppresses Lung Damage in a Murine Model of Idiopathic Pulmonary FibrosisPLOS ONE, 2013
- Methods in cardiomyocyte isolation, culture, and gene transferJournal of Molecular and Cellular Cardiology, 2011
- The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stressNature Medicine, 2007
- Effects of Selective Matrix Metalloproteinase Inhibitor (PG-116800) to Prevent Ventricular Remodeling After Myocardial InfarctionJACC, 2006
- Left ventricular function in patients with chronic kidney disease evaluated by colour tissue Doppler velocity imagingNephrology Dialysis Transplantation, 2005
- Matrix Metalloproteinase Inhibition Attenuates Left Ventricular Remodeling and Dysfunction in a Rat Model of Progressive Heart FailureCirculation, 2001